Redness, a possible signpost for malignant melanoma [10]

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 4, 2005, Pages 514-515

  Mashiah, J ^a   Barnea, Y ^a   Wohl, Y ^a   Brenner, S ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ANGIOGENESIS; BASAL CELL CARCINOMA; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL STUDY; CYTOKINE PRODUCTION; DOPPLER FLOWMETRY; EARLY DIAGNOSIS; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR ESCAPE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ERYTHEMA; FACIAL DERMATOSES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 21744455738     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.01175.x     Document Type: Letter

References (9)

1. Brenner S, Wolf R. The 'red face' - a warning sign of malignant melanoma? Acta Derm Venereol (Stockh) 1992; 72: 464.
2. Tamir E, Brenner S. A case of 'red face': a clue to early detection of malignant melanoma. Skinmed Derm Clinician 2003; 2: 272.
3. Lazar-Molnar E, Hegyesi H, Toth S, Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000; 12: 547-554.
4. Redondo P, Sanchez-Carpintero I, Bauzr A, Idoate M, Solano T, Mihm MC. Immunologic escape and angiogenesis in human malignant melanoma. J Am Acad Dermatol 2003; 49: 255-263.
5. DeMartin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlusener H, Seifert JM, Bodmer S, Fontana A, Hofer E. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J 1987; 6: 3673-3678.
6. Wang Y, Becker D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intramural angiogenesis and tumor growth. Nature Med 1997; 3: 887-893.
7. Salven P, Heikkila P, Joensuu H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 1997; 76: 930-934.
8. Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin Cancer Res 1996; 2: 1969-1979.
9. Tur E, Brenner S. Cutaneous blood flow measurements for the detection of malignancy in pigmented skin lesions. Dermatology 1992; 184: 8-11.